> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Ensemble Orthopedics CMC Osteoarthritis Implant Cleared
- URL: https://www.fdaweb.com/ensemble-orthopedics-cmc-osteoarthritis-implant-cleared/
- Published: 2020-12-04T12:00:00.000Z
- Updated: 2026-09-14T16:39:02.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5148235

FDA has cleared an Ensemble Orthopedics 510(k) for its Ensemble CMC Implant for treating patients with early-stage osteoarthritis of the carpometacarpal (CMC) joint. The device features a proprietary saddle shape that “replaces the natural bearing surfaces of the carpal and metacarpal bones with an interpositional implant that allows for normal, pain-free motion,” the company says. “The Ensemble CMC device is inserted with minimal disruption to the joint capsule and preservation of critical stabilizing soft tissues offering the potential for faster rehabilitation.”